Newsroom

Truth in Hemp™ Newsroom

The need for safe, high-quality, truthful cannabinoid products has never been greater. Through quality, science, scale, and innovation, Folium Biosciences is unlocking the full potential of hemp and is committed to delivering highly refined Broad Spectrum Hemp Oil (0.0% THC) and Full Spectrum Hemp Oil with transparency, excellence, and expertise you won’t find anywhere else in the market. Folium Biosciences is often asked to contribute to various media outlets and answer questions about CBD and the world of hemp. As part of our commitment to always deliver the Truth in HempTM, we are pleased to share the latest resources, information, and company news needed to stay updated on our marketplace. 

Have questions or want to help share the Truth in Hemp™?

Get in touch! We can’t wait to chat.

+
Blog, Media, News

Broad Spectrum Stalk CBD Oil

Folium Biosciences Introduces Broad Spectrum Stalk CBD Oil to Meet Global Demand from Stalk-and-Seed Countries Stalk-and-Seed Formulation Secures Approval for Distribution in Japan and South Korea. Folium Biosciences introduces Broad […]

+
Media, News

Folium Biosciences Names Nutralliance a Preferred U.S. Distributor of Company’s Hemp-Derived Non-Psychoactive Cannabinoid (CBD) Products

Hemp-derived non-psychoactive cannabinoid manufacturer Folium Biosciences and premium-ingredient sales and marketing company Nutralliance have entered a distribution partnership that grants Nutralliance the right to distribute Folium’s industry-leading 0.0% THC broad spectrum CBD oil products in the United States, and establishes Folium as Nutralliance’s exclusive CBD supplier.

+
Media, News

Folium Biosciences Completes Construction of One of the World’s Largest Cannabinoid Extraction and Purification Facilities in Pueblo West, CO

Folium Biosciences has completed buildout and received a Certificate of Occupancy for the world’s largest cannabinoid extraction and purification facility, located in Pueblo West, Colo.

The new 110,000-square-foot Pueblo West facility will produce up to 22,000 kg of 0.0% THC broad spectrum CBD oil each month. To satisfy accelerating demand from CBD product manufacturers worldwide, the plant has dedicated production lines to meet CBD regulatory requirements in the US, EU, Japan, and South Korea, among other countries.

FDA registered and state-of-the-art, the new Folium facility is purpose-built for extraction, purification and formulation of cannabinoids and terpenes. The plant will utilize supercritical carbon dioxide (sCO2) extraction technology exclusively to produce phytocannabinoid-rich 0.0% THC broad spectrum CBD oil, adhering to a continuous process from decarboxylation to extraction that allows for a revolutionary inline terpene capture system.